In our previous study [22], nestin-positive cHCC-CCA was characterized by a smaller tumor size, the more frequent presence of CLC components, a higher rate of p53 mutations, and a higher rate of multiple genetic alterations. Here, NES is linked to cholangiocarcinoma.